Effect of body mass index on the outcome of infections: a systematic review.
about
Obesity, diabetes and pneumonia: the menacing interface of non-communicable and infectious diseases.Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience.Impaired wound healing predisposes obese mice to severe influenza virus infection.Obesity and the risk and outcome of infection.Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season.Impact of weight on immune cell counts among HIV-infected persons.Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjectsAntimicrobial therapy in obesity: a multicentre cross-sectional study.Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology.A refugee's perspective on their neurosurgical care in North America.Obesity and outcomes in patients hospitalized with pneumoniaThe association between obesity and outpatient visits for acute respiratory infections in Ontario, CanadaAssociations between excessive adiposity and seroprevalence of herpes simplex virus type 1 and type 2 among US adults: a population-based age-period-cohort analysis.Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis.Body composition and morphological assessment of nutritional status in adults: a review of anthropometric variables.Cellulitis in Obesity: Adverse Outcomes Affected by Increases in Body Mass Index.When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer.The dangers of extreme body mass index values in patients with Clostridium difficile.Body Mass Index and Risk of Infections Among Women in the Danish National Birth Cohort.Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects.How obesity impacts outcomes of infectious diseases.Information provision for antibacterial dosing in the obese patient: a sizeable absence?Type 2 diabetes mellitus treatment patterns in U.S. nursing home residents.Leptin independently predicts development of sepsis and its outcome.Obesity as a risk factor for Clostridium difficile infection.The effect of obesity on clinical outcomes in presumed sepsis: a retrospective cohort study.Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study.The effect of obesity on antibiotic treatment failure: a historical cohort study.Immediate hematological toxicity of linezolid in healthy volunteers with different body weight: a phase I clinical trial.Low body mass index is associated with impaired quality of life in patients with rheumatoid arthritis.The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning.
P2860
Q30355645-CC69A24C-218C-4A5C-93D9-00D1793309F5Q30394504-9B056E67-1CDC-45D4-B90E-5BC48ED69E48Q30410362-57D1DA4B-CDCA-47E3-AC3E-915561A18194Q30416191-8A10AC4D-8CEB-4861-81B3-11D2A9813A21Q33756909-1923F7B5-79DC-4810-ABFB-E1FFEA3EEA9FQ35066425-F694E0F7-96E6-4967-93CD-7AB43C1D0B93Q35746176-889A5681-4583-44B0-837E-3487BD902F44Q36051579-FAEAACCC-F03A-4FA2-A8A8-93601798E67BQ36111191-4BF78B82-2A37-4586-97AF-12A69823F478Q36300787-7B433A45-AB03-447A-BB68-9F27B04933B8Q36674892-884A8ED2-88F3-4445-A173-6EE72135B21BQ37259897-093A0FD6-A842-45BC-ABF2-2241C5ECDD99Q37356005-EE1D821A-888A-4B5A-B346-4ACA706489CDQ37860354-BB0FDA05-7577-4595-B485-68ADB11BE546Q38270947-1CB28E65-B4FE-4FF7-997A-DEED1DF686B0Q38450151-EAA52BE5-46F7-418D-9886-C79E432A0A83Q38543908-21963045-F1FC-4B5E-80AA-632567F15BDEQ38737003-B160D619-A2AB-4BFE-BDB9-12EACFB4E6C0Q39759200-480282FE-70B4-41D1-B3DE-9FBCE8C10CC9Q39883684-73645D10-8667-484A-8E01-CB00A6CF6197Q40210571-CE463D7B-3D2F-4093-B657-3A4CF8E3E322Q40444634-17635DF2-6021-4DF2-B6AA-9601AB094568Q40570741-2763B588-8361-4EC3-B39C-B05E3A7DC525Q41104446-B1346603-34D6-4F27-8AB4-8C033F46C2F0Q41274146-65F8F899-D0D0-4B7F-AC28-EED60B52E279Q42264118-40E99BD7-632F-45EF-918D-65268C801C90Q43827300-9F163C36-1496-4DA8-B65E-F7888954F634Q45375548-8C01B391-7BDD-441A-BECB-D8443FAD8927Q45711553-4BA34A59-8C2C-4870-A7F8-B1C6F61D7E2AQ47329892-FD7340B5-CFCA-4180-AE38-4250A237B09CQ47687959-18587BC3-5EA0-4CFF-960C-016A66408869Q50986151-B12C07FD-0B4B-451F-A94C-29D140730343
P2860
Effect of body mass index on the outcome of infections: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of body mass index on the outcome of infections: a systematic review.
@en
Effect of body mass index on the outcome of infections: a systematic review.
@nl
type
label
Effect of body mass index on the outcome of infections: a systematic review.
@en
Effect of body mass index on the outcome of infections: a systematic review.
@nl
prefLabel
Effect of body mass index on the outcome of infections: a systematic review.
@en
Effect of body mass index on the outcome of infections: a systematic review.
@nl
P2093
P2860
P1433
P1476
Effect of body mass index on the outcome of infections: a systematic review
@en
P2093
A P Athanasoulia
M E Falagas
P2860
P304
P356
10.1111/J.1467-789X.2008.00546.X
P577
2008-02-11T00:00:00Z